6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: June 6, 2011
Period of Report: June 6, 2011
Accession Number: 0001144204-11-034015

View Document ↗ View on SEC.gov ↗